Suppr超能文献

S32006,一种新型5-羟色胺2C受体拮抗剂,在啮齿动物模型中显示出广泛的抗抑郁和抗焦虑特性。

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

作者信息

Dekeyne Anne, Mannoury la Cour Clotilde, Gobert Alain, Brocco Mauricette, Lejeune Françoise, Serres Florence, Sharp Trevor, Daszuta Annie, Soumier Amélie, Papp Mariusz, Rivet Jean-Michel, Flik Gunnar, Cremers Thomas I, Muller Olivier, Lavielle Gilbert, Millan Mark J

机构信息

Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 chemin de Ronde, Croissy/Seine, France.

出版信息

Psychopharmacology (Berl). 2008 Sep;199(4):549-68. doi: 10.1007/s00213-008-1177-9. Epub 2008 Jun 4.

Abstract

RATIONALE

Serotonin (5-HT)(2C) receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive states.

OBJECTIVES

Herein, we characterized the in vitro and in vivo pharmacological profile of the novel benzourea derivative, S32006.

MATERIALS AND METHODS

Standard cellular, electrophysiological, neurochemical, and behavioral procedures were used.

RESULTS

S32006 displayed high affinity for human (h)5-HT(2C) and h5-HT(2B) receptors (pK (i)s, 8.4 and 8.0, respectively). By contrast, it had negligible (100-fold lower) affinity for h5-HT(2A) receptors and all other sites examined. In measures of Gq-protein coupling/phospholipase C activation, S32006 displayed potent antagonist properties at h5-HT(2C) receptors (pK (B) values, 8.8/8.2) and h5-HT(2B) receptors (7.8/7.7). In vivo, S32006 dose-dependently (2.5-40.0 mg/kg, i.p. and p.o.) abolished the induction of penile erections and a discriminative stimulus by the 5-HT(2C) receptor agonist, Ro60,0175, in rats. It elevated dialysis levels of noradrenaline and dopamine in the frontal cortex of freely moving rats, and accelerated the firing rate of ventrotegmental dopaminergic and locus ceruleus adrenergic neurons. At similar doses, S32006 decreased immobility in a forced-swim test in rats, reduced the motor depression elicited by 5-HT(2C) and alpha(2)-adrenoceptor agonists, and inhibited both aggressive and marble-burying behavior in mice. Supporting antidepressant properties, chronic (2-5 weeks) administration of S32006 suppressed "anhedonia" in a chronic mild stress procedure and increased both expression of BDNF and cell proliferation in rat dentate gyrus. Finally, S32006 (0.63-40 mg/kg, i.p. and p.o) displayed anxiolytic properties in Vogel conflict and social interaction tests in rats.

CONCLUSION

S32006 is a potent 5-HT(2C) receptor antagonist, and possesses antidepressant and anxiolytic properties in diverse rodent models.

摘要

理论依据

血清素(5-羟色胺,5-HT)(2C)受体参与情绪控制,其阻断作用对于焦虑抑郁状态的治疗具有潜在意义。

目的

在此,我们对新型苯脲衍生物S32006的体外和体内药理学特性进行了表征。

材料与方法

采用标准的细胞、电生理、神经化学和行为学实验方法。

结果

S32006对人(h)5-HT(2C)和h5-HT(2B)受体表现出高亲和力(pK(i)值分别为8.4和8.0)。相比之下,它对h5-HT(2A)受体及所有其他检测位点的亲和力可忽略不计(低100倍)。在Gq蛋白偶联/磷脂酶C激活检测中,S32006在h5-HT(2C)受体(pK(B)值为8.8/8.2)和h5-HT(2B)受体(7.8/7.7)上表现出强效拮抗特性。在体内,S32006剂量依赖性地(腹腔注射和口服,2.5 - 40.0 mg/kg)消除了5-HT(2C)受体激动剂Ro60,0175在大鼠中诱导的阴茎勃起和辨别性刺激。它提高了自由活动大鼠额叶皮质中去甲肾上腺素和多巴胺的透析水平,并加快了腹侧被盖区多巴胺能神经元和蓝斑去甲肾上腺素能神经元的放电频率。在相似剂量下,S32006减少了大鼠强迫游泳试验中的不动时间,减轻了5-HT(2C)和α(2)-肾上腺素能受体激动剂引起的运动抑制,并抑制了小鼠的攻击行为和埋大理石行为。支持其具有抗抑郁特性的是,S32006慢性(2 - 5周)给药可在慢性轻度应激实验中抑制“快感缺失”,并增加大鼠齿状回中脑源性神经营养因子(BDNF)的表达和细胞增殖。最后,S32006(腹腔注射和口服,0.63 - 40 mg/kg)在大鼠的Vogel冲突试验和社交互动试验中表现出抗焦虑特性。

结论

S32006是一种强效的5-HT(2C)受体拮抗剂,在多种啮齿动物模型中具有抗抑郁和抗焦虑特性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验